PositoAI
a positivity index
Home Categories Fund houses World
Funds › India › Equity › Sectoral / Thematic › Invesco India Pharma and Healthcare Fund

Invesco India Pharma and Healthcare Fund

Invesco Mutual Fund · Equity · Sectoral / Thematic · Open ended · History since Sep 2026
₹8.95 -0.2% · NAV on 23 Oct 2026 · Direct Growth

← Fund Positivity Score and ranks

Direct · GrowthDirect · IDCWRegular · GrowthRegular · IDCW

Returns Direct Growth · up to 1 year simple %, longer periods yearly average

1 month-11.4%
3 months—
6 months—
1 year—
3 years—
5 years—
10 years—
Since start—

NAV history

Ups and downs

Worst fall from a peak (last 5 years)-11.4%
Peak → lowSep 2026 → Oct 2026
Volatility (last year)—

Volatility shows how much the NAV usually swings in a year; higher means bigger ups and downs.

About this fund

Fund houseInvesco Mutual Fund
CategoryEquity · Sectoral / Thematic
TypeOpen ended
Scheme code · ISIN154547 · INF205KA1BX5

Same category Sectoral / Thematic · current funds · by 3-year return

Fund1 year3 years5 years
Nippon India Taiwan Equity FundNippon India Mutual Fund +93.6% +57.0% —
HDFC Defence FundHDFC Mutual Fund +11.4% +34.0% —
HDFC Pharma and Healthcare FundHDFC Mutual Fund +15.9% +28.0% —
Nippon India Japan Equity FundNippon India Mutual Fund +25.3% +23.7% +10.8%
Aditya Birla Sun Life International Equity FundAditya Birla Sun Life Mutual Fund +16.0% +22.9% +11.5%
Invesco India Pharma and Healthcare FundInvesco Mutual Fund · this fund — — —

255 current funds in Sectoral / Thematic · see all →. Funds are compared only within the same SEBI category.

All versions of this fund

PlanOptionNAV (₹)NAV dateScheme code
DirectGrowth 8.95 23 Oct 2026 154547
DirectIDCW 8.95 23 Oct 2026 154546
RegularGrowth 8.93 23 Oct 2026 154545
RegularIDCW 8.93 23 Oct 2026 154544

Direct plans are bought straight from the fund house and cost less; Regular plans include a distributor's commission. Growth keeps profits invested; IDCW pays them out from time to time.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.